Perspectives on benefits and risks of creation of an “injection drug use” billing code

By sjmartinez • May 13, 2024

Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG. Perspectives on benefits and risks of creation of an "injection drug use" billing code. J Subst Use Addict Treat. 2024 May 10:209392. doi: 10.1016/j.josat.2024.209392. Epub ahead of print. PMID: 38735482.

Tags: Infectious Diseases, Publications

Executive Orders and Caring for Our Transgender Patients

Vijayan T. Executive Orders and Caring for Our Transgender Patients. Clin Infect Dis. 2025 Apr 15:ciaf128. doi: 10.1093/cid/ciaf128. Epub ahead of print. PMID: 40230088.

Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort

Davies Smith E, Malvestutto C, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Watanabe M, Bloomfield GS, Currier JS, Chu SM, Fitch KV, Diggs MR, Bedimo R,[...]

A Case of HIV-Associated Primary Central Nervous System Lymphoma Refractory to Methotrexate-Based Systemic Therapy and Immune Reconstitution

Cleveland JM, Cleveland HA, Chamberlain E, Sinclair J, Ku N, Schachter L, Di Carlo BA. A Case of HIV-Associated Primary Central Nervous System Lymphoma Refractory[...]